Research output per year
Research output per year
Research activity per year
Bart van der Worp is a neurologist with a special interest in cerebrovascular diseases at the University Medical Center in Utrecht, the Netherlands. He has been (co-)Chief Investigator of the randomised stroke trials HAMLET, PAIS, COOLIST, VAST, APACHE-AF, and MR ASAP and is Chief Investigator of PRECIOUS. He is a member of the Dutch CONTRAST consortium which aims to identify and test new treatments for patients with acute ischaemic stroke or intracerebral haemorrhage. He is former President of the European Stroke Organisation.
2008 – fellow of the European Stroke Organisation (ESO)
2011 – 2022 member of the Board of Directors of ESO
2011 – 2016 member of the Committee for Professional Interests (BBC) of the NVN
2013 – 2015 member of the Committee for Clinical trials of ESO
2013 – 2017 member of the Guideline Committee of ESO
2014 – 2016 vice-president ESO
2014 – 2021 member of the writing committee of the Dutch Stroke Guideline
2016 – 2018 president-elect ESO
2018 – 2020 president ESO
2019 – 2021 member of Committee on emergency prehospital care (45-minutennorm) of the Gezondheidsraad
2019 - 2020 consultant, Bayer
2020 – 2022 past president ESO
2020 – 2021 Chair module writing group ESO guideline on space-occupying oedema
2022 - consultant, TargED
2022 - national coordinator randomised trial, Bayer
Member of Data and Safety Monitoring Boards of randomised trials
2005 – 2007 Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis
2009 – 2011 Intrathecal methylprednisolone for intractable postherpetic neuralgia: STIP study. (Steroids for Intractable Postherpetic Neuralgia)
2009 – 2011 A randomised sequential trial of Lithium In amyotrophic lateral sclerosis
2015 – 2021 TELSTAR: Treatment of electroencephalographic status epilepticus after cardiopulmonary resuscitation - a randomized controlled trial (Chair)
2018 – 2019 PHALS: A placebo-controlled double blind randomized trial to investigate the efficacy and safety of the combination of Penicillin G / Hydrocortisone treatment in ALS patients (Chair)
2018 – RESSTORE: Regenerative Stem Cell Therapy for Stroke in Europe
2019 – GRECO: Ghrelin treatment of comatose patients after cardiac arrest: A phase 2 clinical trial to estimate safety and efficacy of ghrelin to promote cerebral (Chair)
national coordinator of an international trial - national coordination of this trial - Bayer
4 Mar 2024 → 31 Dec 3999
consultant - giving advice - TargED
1 Jan 2022 → 31 Dec 3999
Research output: Contribution to journal › Article › Academic › peer-review
Research output: Contribution to journal › Article › Academic › peer-review
Research output: Contribution to journal › Article › Academic › peer-review
Research output: Contribution to journal › Article › Academic › peer-review
Research output: Contribution to journal › Article › Academic › peer-review